STAT3, a Master Regulator of Anti-Tumor Immune Response
- PMID: 31480382
- PMCID: PMC6770459
- DOI: 10.3390/cancers11091280
STAT3, a Master Regulator of Anti-Tumor Immune Response
Abstract
Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on the role of STAT3 and its regulation, e.g. by phosphorylation or acetylation in immune cells and how it might impact immune cell function and tumor progression. Moreover, we will review the ability of STAT3 to regulate checkpoint inhibitors.
Keywords: CD4+ T cells; CD8+ T cells; STAT3; cancer; immune check point.; myeloid cells.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
STAT3 activation: A key factor in tumor immunoescape.JAKSTAT. 2013 Jan 1;2(1):e23010. doi: 10.4161/jkst.23010. JAKSTAT. 2013. PMID: 24058791 Free PMC article. Review.
-
Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer.Pharm Front. 2019;1:e190007. doi: 10.20900/pf20190007. Epub 2019 Nov 28. Pharm Front. 2019. PMID: 31886474 Free PMC article.
-
High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway.Cancer Commun (Lond). 2023 May;43(5):562-581. doi: 10.1002/cac2.12420. Epub 2023 Apr 8. Cancer Commun (Lond). 2023. PMID: 37031362 Free PMC article.
-
Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.Arch Pharm Res. 2016 Aug;39(8):1085-99. doi: 10.1007/s12272-016-0795-8. Epub 2016 Aug 11. Arch Pharm Res. 2016. PMID: 27515050 Review.
-
STAT3: a target to enhance antitumor immune response.Curr Top Microbiol Immunol. 2011;344:41-59. doi: 10.1007/82_2010_51. Curr Top Microbiol Immunol. 2011. PMID: 20517723 Free PMC article. Review.
Cited by
-
Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy.Vaccines (Basel). 2020 Dec 4;8(4):735. doi: 10.3390/vaccines8040735. Vaccines (Basel). 2020. PMID: 33291616 Free PMC article. Review.
-
At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma.Front Oral Health. 2021 Mar 5;2:647980. doi: 10.3389/froh.2021.647980. eCollection 2021. Front Oral Health. 2021. PMID: 35047999 Free PMC article. Review.
-
Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.J Enzyme Inhib Med Chem. 2023 Dec;38(1):2201408. doi: 10.1080/14756366.2023.2201408. J Enzyme Inhib Med Chem. 2023. PMID: 37096557 Free PMC article.
-
Coagulation Protease-Driven Cancer Immune Evasion: Potential Targets for Cancer Immunotherapy.Cancers (Basel). 2024 Apr 19;16(8):1568. doi: 10.3390/cancers16081568. Cancers (Basel). 2024. PMID: 38672649 Free PMC article. Review.
-
Inflammatory Networks in Renal Cell Carcinoma.Cancers (Basel). 2023 Apr 9;15(8):2212. doi: 10.3390/cancers15082212. Cancers (Basel). 2023. PMID: 37190141 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous